Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/28/1993 | CA2117779A1 T cell epitopes of the major allergens from ambrosia artemisifolia |
10/28/1993 | CA2117756A1 Oligonucleotide sequences and transgenic animals transfected therewith having reduced sensitivity to narcotic analgesics |
10/28/1993 | CA2117747A1 A novel hyaluronan receptor protein and novel hyaluronan binding peptides |
10/28/1993 | CA2111565A1 Plants resistant against plural viruses and method for producing them |
10/27/1993 | EP0567100A1 Mutant respiratory syncytial virus (RSV) vaccines containing same and methods of use |
10/27/1993 | EP0566897A2 The complete gene (cefG) encoding the acetyl-CoA: deacetylcephalosporin C acetyltransferase of Cephalosporium acremonium, its isolation and use |
10/27/1993 | EP0566751A1 DNA detection method |
10/27/1993 | EP0566732A1 Adeno-associated virus-2 basal vectors |
10/27/1993 | EP0566714A1 Coupled transcription and translation in eukaryotic cell-free extract. |
10/27/1993 | EP0566673A1 Biosynthetic pdgf antagonists |
10/27/1993 | EP0566647A1 Improved humanized immunoglobulins |
10/27/1993 | EP0566630A1 Process for the synthesis and purification of human ciliary neuronotrophic factor (cntf) from escherichia coli |
10/27/1993 | EP0566611A1 Analogs of piscine lhrh |
10/27/1993 | EP0566596A1 Increased expression by a second transferred sequence in transgenic organisms |
10/27/1993 | EP0566579A1 Insect-specific paralytic neurotoxin genes for use in biological insect control: methods and compositions |
10/26/1993 | US5256770 Oxidation resistant thrombomodulin analogs |
10/26/1993 | US5256648 Selective inhibition of gene expression by photoactivatable oligonucleotides |
10/26/1993 | US5256642 Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof |
10/26/1993 | US5256568 Antibiotic resistance |
10/26/1993 | US5256561 Monoclonal antibody to HIV-2 and uses thereof |
10/26/1993 | US5256558 Gene encoding plant asparagine synthetase |
10/26/1993 | US5256554 Expression of human immunodeficiency virus (HIV) reverse transcriptase |
10/26/1993 | US5256553 Multiple promoter transforming retroviral vectors |
10/26/1993 | US5256546 Plasmid which upon introduction into bacterial host renders host capable of effecting expression of growth hormone |
10/26/1993 | US5256545 Sterol Regulatory Elements |
10/26/1993 | US5256536 Hybridization |
10/26/1993 | CA1323592C Method of detecting nucleotide sequences |
10/22/1993 | CA2094221A1 Stable isoforms of creatine kinase for standard markers and diagnosis |
10/21/1993 | CA2093735A1 Amyloid precursor-like protein and uses thereof |
10/20/1993 | EP0566554A2 Production of recombinant proteins using herpes virus promoters and VP16 transactivators |
10/20/1993 | EP0566525A2 Recombinant tospovirus DNA constructs and plants comprising such constructs |
10/20/1993 | EP0566410A2 Derivatives of adipogenesis inhibitory factor, their preparation and their use |
10/20/1993 | EP0566198A2 In vitro gene selection by means of RNA carriers |
10/20/1993 | EP0566158A1 The use of alpha-1-antitrypsin mutants in the manufacture of medicaments, and therapeutic formulations using mutants and their preparation |
10/20/1993 | EP0566066A1 Antigens of human non-small lung carcinoma |
10/20/1993 | EP0565638A1 Tumor susceptible non-human animals |
10/20/1993 | EP0565626A1 Fusions of a viral protein and a destructive enzyme |
10/20/1993 | EP0565590A1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE) |
10/19/1993 | US5254801 Inducing male sterility for hybrid seed production, cell ablation, counter-negative selection; genetic engineering |
10/19/1993 | US5254800 Tomato plants and cells containing pTOM36 antisense constructs |
10/19/1993 | US5254799 Transformation vectors allowing expression of Bacillus thuringiensis endotoxins in plants |
10/19/1993 | US5254678 Ribozymes |
10/19/1993 | US5254671 Extracellular segments of human e immunoglobulin anchoring peptides and antibodies specific therefor |
10/19/1993 | US5254470 Alkaline protease, alkaline protease gene, recombinant DNA, DNA fragment for the expression of gene, and process for the production of alkaline protease |
10/19/1993 | US5254466 Site-specific modification of the candida tropicals genome |
10/19/1993 | US5254463 Method for expression of bovine growth hormone |
10/19/1993 | US5254462 Genetic engineering |
10/19/1993 | CA1323318C Methods for preparing proteins of altered structure |
10/19/1993 | CA1323317C Production of fibroblast growth factor |
10/19/1993 | CA1323293C Assay using template-dependent nucleic acid probe reorganization |
10/18/1993 | CA2094177A1 Derivatives of adipogenesis inhibitory factor, their preparation and their use |
10/15/1993 | CA2087787A1 Cloning and characterization of a gene, inducible by cytokines |
10/14/1993 | WO1993020439A1 Compositions and methods for regulating cellular signal transducing systems |
10/14/1993 | WO1993020434A1 Electrophoresis of nucleic acid fragments |
10/14/1993 | WO1993020242A1 Encoded combinatorial chemical libraries |
10/14/1993 | WO1993020241A1 Methods for inactivating nucleotide sequences and metal chelates for use therein |
10/14/1993 | WO1993020240A1 Method and device for detection of nucleic acid or analyte using total internal reflectance |
10/14/1993 | WO1993020239A1 Probe method and composition for detecting different dna sequences |
10/14/1993 | WO1993020238A2 Amplification of human mdm2 gene in human tumors |
10/14/1993 | WO1993020237A1 Homology cloning |
10/14/1993 | WO1993020236A1 Probe composition and method |
10/14/1993 | WO1993020235A1 Methods of detecting mammalian nucleic acids isolated from stool specimen and reagents therefor |
10/14/1993 | WO1993020232A1 Method of sequencing |
10/14/1993 | WO1993020229A1 ANTIBODIES TO ALPHAvBETA3 INTEGRIN |
10/14/1993 | WO1993020227A1 Method of multiplex ligase chain reaction |
10/14/1993 | WO1993020221A1 Gene therapy using targeted viral vectors |
10/14/1993 | WO1993020220A1 Non-infectious hiv particles and uses therefor |
10/14/1993 | WO1993020219A1 Control and/or prevention of binding of nf-kb/rel/dorsal (nrd) family proteins to dna |
10/14/1993 | WO1993020218A1 Synthetic eukaryotic promoters containing two inducible elements |
10/14/1993 | WO1993020217A1 Plant virus vector, plasmid, method of expressing foreign gene, and method of acquiring foreign gene product |
10/14/1993 | WO1993020216A1 Oil-body protein cis-elements as regulatory signals |
10/14/1993 | WO1993020215A1 Process for producing recombinant proteins in steptomycetes |
10/14/1993 | WO1993020214A1 Heterologous gene expression in bacillus subtilis: fusion approach |
10/14/1993 | WO1993020212A1 METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS OF mRNA |
10/14/1993 | WO1993020211A1 A method of limiting the survival of genetically engineered microorganisms in their environment |
10/14/1993 | WO1993020210A1 Antibodies for treatment and prevention of respiratory syncytial virus infection |
10/14/1993 | WO1993020209A1 Methods for producing substantially pure eg iii cellulase using alcohol |
10/14/1993 | WO1993020208A1 Methods for producing substantially pure eg iii cellulase using polyethylene glycol |
10/14/1993 | WO1993020206A1 Genetic sequences encoding flavonoid pathway enzymes and uses therefor |
10/14/1993 | WO1993020205A1 ANTI-HBs ANTIBODY GENE AND EXPRESSION PLASMID THEREOF |
10/14/1993 | WO1993020204A1 Monomeric platelet-derived growth factor and prevention of stenosis or restenosis |
10/14/1993 | WO1993020203A2 Stability-enhanced variants of parathyroid hormone |
10/14/1993 | WO1993020202A1 Decorin fragments and methods of inhibiting cell regulatory factors |
10/14/1993 | WO1993020201A1 GAP-ASSOCIATED PROTEIN p190 AND TRANSDUCTION |
10/14/1993 | WO1993020200A1 Modified cells and method of treatment |
10/14/1993 | WO1993020198A1 INTERSEXUAL HETEROZYGOUS $i(PHYCOMYCES) |
10/14/1993 | WO1993020197A1 Stem cell proliferation factor |
10/14/1993 | WO1993020196A1 Cloning, expression and uses of a novel secreted protein, f-spondin |
10/14/1993 | WO1993020194A1 Tpa analog |
10/14/1993 | WO1993020193A1 ENDO-β-1,4-GLUCANASE AND A DNA SEQUENCE |
10/14/1993 | WO1993020190A1 A novel enzyme and a dna sequence |
10/14/1993 | WO1993020189A1 Process for the production of a viable cell culture infected by a multiple sclerosis associated virus |
10/14/1993 | WO1993020188A1 Process and culture medium for the production of cells infected by a multiple sclerosis associated virus |
10/14/1993 | WO1993020187A1 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon |
10/14/1993 | WO1993020106A1 Protein cellular factor useful for regulating gene expression |
10/14/1993 | WO1993020101A1 Inhibitor of protein kinase c |
10/14/1993 | WO1993020096A1 Oligonucleotide libraries useful for producing primers |
10/14/1993 | WO1993020095A1 Antisense oligonucleotide inhibition of papillomavirus |
10/14/1993 | WO1993020093A1 Hybrid human/porcine factor viii |
10/14/1993 | WO1993020092A1 Synthesis of oligonucleotides |